Interplay between reversible phosphorylation and irreversible ADP-ribosylation of eukaryotic translation elongation factor 2

Abstract The functionality of eukaryotic translation elongation factor 2 (eEF2) is modulated by phosphorylation, eEF2 is simultaneously the molecular target of ADP-ribosylating toxins. We analyzed the interplay between phosphorylation and diphthamide-dependent ADP-ribosylation. Phosphorylation does not require diphthamide, eEF2 without it still becomes phosphorylated. ADP-ribosylation not only modifies the H715 diphthamide but also inhibits phosphorylation of S595 located in proximity to H715, and stimulates phosphorylation of T56. S595 can be phosphorylated by CDK2 and CDK1 which affects EEF2K-mediated T56-phosphorylation. Thus, ADP-ribosylation and S595-phosphorylation by kinases occur within the same vicinity and both trigger T56-phosphorylation. Diphthamide is surface-accessible permitting access to ADP-ribosylating enzymes, the adjacent S595 side chain extends into the interior. This orientation is incompatible with phosphorylation, neither allowing kinase access nor phosphate attachment. S595 phosphorylation must therefore be accompanied by structural alterations affecting the interface to ADP-ribosylating toxins. In agreement with that, replacement of S595 with Ala, Glu or Asp prevents ADP-ribosylation. Phosphorylation (starvation) as well as ADP-ribosylation (toxins) inhibit protein synthesis, both affect the S595/H715 region of eEF2, both trigger T57-phosphorylation eliciting similar transcriptional responses. Phosphorylation is short lived while ADP-ribosylation is stable. Thus, phosphorylation of the S595/H715 ‘modifier region’ triggers transient interruption of translation while ADP-ribosylation arrests irreversibly.

[1]  U. Brinkmann,et al.  Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADP-Ribosylating Toxins , 2017, Toxins.

[2]  I. Pastan,et al.  New Life for Immunotoxin Cancer Therapy , 2015, Clinical Cancer Research.

[3]  I. Pastan,et al.  Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor , 2015, Proceedings of the National Academy of Sciences.

[4]  Rajarshi Guha,et al.  Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity , 2015, Proceedings of the National Academy of Sciences.

[5]  M. Stark,et al.  The diphthamide modification pathway from Saccharomyces cerevisiae – revisited , 2014, Molecular microbiology.

[6]  J. Freed,et al.  Dph3 Is an Electron Donor for Dph1-Dph2 in the First Step of Eukaryotic Diphthamide Biosynthesis , 2014, Journal of the American Chemical Society.

[7]  Hening Lin,et al.  The biosynthesis and biological function of diphthamide , 2013, Critical reviews in biochemistry and molecular biology.

[8]  I. Pastan,et al.  Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8. , 2013, Leukemia research.

[9]  V. P. Collins,et al.  The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation , 2013, Cell.

[10]  I. Pastan,et al.  A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of the WDR85 Gene* , 2013, The Journal of Biological Chemistry.

[11]  B. Clurman,et al.  Phosphorylation of Eukaryotic Elongation Factor 2 (eEF2) by Cyclin A–Cyclin-Dependent Kinase 2 Regulates Its Inhibition by eEF2 Kinase , 2012, Molecular and Cellular Biology.

[12]  S. Leppla,et al.  Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development , 2012, Proceedings of the National Academy of Sciences.

[13]  J. Shan,et al.  The transcription factor network associated with the amino acid response in mammalian cells. , 2012, Advances in nutrition.

[14]  I. Pastan,et al.  Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy , 2012, Proceedings of the National Academy of Sciences.

[15]  K. Glaser,et al.  1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) Induces Phosphorylation of Eukaryotic Elongation Factor-2 (eEF2) , 2011, The Journal of Biological Chemistry.

[16]  G. Kaul,et al.  Eukaryotic elongation factor‐2 (eEF2): its regulation and peptide chain elongation , 2011, Cell biochemistry and function.

[17]  H. Baker,et al.  Expression profiling after activation of amino acid deprivation response in HepG2 human hepatoma cells. , 2010, Physiological genomics.

[18]  S. Cross,et al.  Diphthamide modification of eEF2 requires a J-domain protein and is essential for normal development , 2008, Journal of Cell Science.

[19]  A. R. Merrill,et al.  The nature and character of the transition state for the ADP‐ribosyltransferase reaction , 2008, EMBO reports.

[20]  G. Lajoie,et al.  The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A. , 2008, The Biochemical journal.

[21]  Ira Pastan,et al.  Immunotoxin therapy of cancer , 2006, Nature Reviews Cancer.

[22]  K. Miyagawa,et al.  Gene Trap Mutagenesis-based Forward Genetic Approach Reveals That the Tumor Suppressor OVCA1 Is a Component of the Biosynthetic Pathway of Diphthamide on Elongation Factor 2* , 2005, Journal of Biological Chemistry.

[23]  D. Vertommen,et al.  Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis , 2002, Current Biology.

[24]  R. Collier,et al.  DPH5, a methyltransferase gene required for diphthamide biosynthesis in Saccharomyces cerevisiae , 1992, Molecular and cellular biology.

[25]  W. Merrick.  Mechanism and regulation of eukaryotic protein synthesis. , 1992, Microbiological reviews.

[26]  C. Proud,et al.  Identification of the phosphorylation sites in elongation factor‐2 from rabbit reticulocytes , 1991, FEBS letters.

[27]  L. Ovchinnikov,et al.  Three phosphorylation sites in elongation factor 2 , 1990, FEBS letters.

[28]  J. Howard,et al.  ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. , 1980, The Journal of biological chemistry.

[29]  I. Pastan,et al.  Factors that Determine Sensitivity and Resistances of Tumor Cells Towards Antibody-Targeted Protein Toxins , 2015 .

[30]  J. Shan,et al.  Dynamic changes in genomic histone association and modification during activation of the ASNS and ATF3 genes by amino acid limitation. , 2013, The Biochemical journal.

[31]  A. Schroeder.  Influence of DPH 1 and DPH 5 Protein Variants on the Synthesis of Diphthamide , the Target of ADP ‐ , 2022 .